ORAGENICS, INC. Operating Lease, Liability, Current
ORAGENICS, INC. (OGEN) had Operating Lease, Liability, Current of $9.81 thousand as of 2023-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Notes
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-03-14
- 2023-12-31: Operating Lease, Liability, Current $9.81K.
- 2023-09-30: Operating Lease, Liability, Current $24.34K.
- 2023-06-30: Operating Lease, Liability, Current $190.24K.
- 2023-03-31: Operating Lease, Liability, Current $202.19K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-12-31 | $9.81K 10-K · filed 2025-03-14 |
| 2023-09-30 | $24.34K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $190.24K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $202.19K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $204.45K 10-K · filed 2024-03-29 |
| 2022-09-30 | $201.97K 10-Q/A · filed 2023-04-14 |
| 2022-06-30 | $180.82K 10-Q/A · filed 2023-04-14 |
| 2022-03-31 | $192.53K 10-Q/A · filed 2023-04-14 |
| 2021-12-31 | $194.27K 10-K · filed 2023-04-17 |
| 2021-09-30 | $190.18K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $185.69K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $181.26K 10-Q · filed 2021-05-03 |
| 2020-12-31 | $176.90K 10-K/A · filed 2022-07-29 |
| 2020-09-30 | $173.54K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $170.68K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $167.86K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $165.10K 10-K · filed 2021-03-01 |
| 2019-09-30 | $135.12K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $140.33K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $132.47K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |